Kintor Pharmaceutical Limited (HKG:9939)

Kintor Pharmaceutical Statistics

Total Valuation

HKG:9939 has a market cap or net worth of HKD 1.35 billion. The enterprise value is 1.41 billion.

Market Cap	1.35B
Enterprise Value	1.41B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:9939 has 493.52 million shares outstanding. The number of shares has increased by 4.42% in one year.

Current Share Class	493.52M
Shares Outstanding	493.52M
Shares Change (YoY)	+4.42%
Shares Change (QoQ)	+7.23%
Owned by Insiders (%)	11.77%
Owned by Institutions (%)	0.15%
Float	380.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	37.05
PB Ratio	6.63
P/TBV Ratio	16.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.32
EV / Sales	38.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.42

Financial Position

The company has a current ratio of 0.43, with a Debt / Equity ratio of 0.47.

Current Ratio	0.43
Quick Ratio	0.28
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	-0.51
Interest Coverage	-43.72

Financial Efficiency

Return on equity (ROE) is -83.96% and return on invested capital (ROIC) is -30.96%.

Return on Equity (ROE)	-83.96%
Return on Assets (ROA)	-25.18%
Return on Invested Capital (ROIC)	-30.96%
Return on Capital Employed (ROCE)	-80.87%
Weighted Average Cost of Capital (WACC)	1.93%
Revenue Per Employee	295,682
Profits Per Employee	-1.81M
Employee Count	123
Asset Turnover	0.08
Inventory Turnover	3.44

Taxes

Income Tax	-3.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +145.95% in the last 52 weeks. The beta is -0.44, so HKG:9939's price volatility has been lower than the market average.

Beta (5Y)	-0.44
52-Week Price Change	+145.95%
50-Day Moving Average	2.94
200-Day Moving Average	2.37
Relative Strength Index (RSI)	45.60
Average Volume (20 Days)	4,780,396

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9939 had revenue of HKD 36.37 million and -222.68 million in losses. Loss per share was -0.50.

Revenue	36.37M
Gross Profit	8.95M
Operating Income	-191.89M
Pretax Income	-225.85M
Net Income	-222.68M
EBITDA	-156.52M
EBIT	-191.89M
Loss Per Share	-0.50

Balance Sheet

The company has 36.43 million in cash and 96.37 million in debt, with a net cash position of -59.94 million or -0.12 per share.

Cash & Cash Equivalents	36.43M
Total Debt	96.37M
Net Cash	-59.94M
Net Cash Per Share	-0.12
Equity (Book Value)	203.19M
Book Value Per Share	0.44
Working Capital	-80.49M

Cash Flow

In the last 12 months, operating cash flow was -188.89 million and capital expenditures -778,967, giving a free cash flow of -189.66 million.

Operating Cash Flow	-188.89M
Capital Expenditures	-778,967
Depreciation & Amortization	36.48M
Net Borrowing	-53.72M
Free Cash Flow	-189.66M
FCF Per Share	-0.38

Margins

Gross Margin	24.60%
Operating Margin	-527.63%
Pretax Margin	-621.01%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:9939 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.42%
Shareholder Yield	-4.42%
Earnings Yield	-16.53%
FCF Yield	-14.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3